PRP superior to corticosteroid for plantar fasciitis; nonsuperior in lateral epicondylitis .
Local injection of autologous platelet rich plasma and corticosteroid in treatment of lateral epicondylitis and plantar fasciitis: randomized clinical trial
The Egyptian Rheumatologist: Vol 34, Issue 2, April 2012, Pages 43-4930 patients with lateral epicondylitis and 30 patients with plantar fasciitis were randomized to determine the efficacy of platelet-rich plasma injection in the treatment of both conditions. A 1:1 ratio of patients from each cohort were allocated to receive either injection of PRP or corticosteroid, and were followed-up for 6 weeks thereafter in outcomes of pain and function. Results at 6 weeks in patients with plantar fasciitis indicated that while both treatments significantly improved pain and function, patients treated with PRP had a greater degree of improvement. In patients with lateral epicondylitis, similar pain and functional outcome was observed between PRP and corticosteroid injections.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
